Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0H7PW
|
|||
| Former ID |
DNC014176
|
|||
| Drug Name |
PIPERINE
|
|||
| Synonyms |
piperine; 94-62-2; 1-Piperoylpiperidine; Piperin; Bioperine; Piperoylpiperidine; (E,E)-1-piperoylpiperidine; N-[(E,E)-Piperoyl]piperidine; Piperidine, 1-piperoyl-, (E,E)-; UNII-U71XL721QK; FEMA No. 2909; CCRIS 5572; Piperine (aliphatic); 1-Piperoylpiperidine, (E,E)-; 7780-20-3; C17H19NO3; EINECS 202-348-0; NSC 21727; 1-[(2E,4E)-5-(1,3-benzodioxol-5-yl)penta-2,4-dienoyl]piperidine; N-(E,E)-piperoyl-piperidine; CHEMBL43185; U71XL721QK; CHEBI:28821; MXXWOMGUGJBKIW-YPCIICBESA-N; NSC21727; piperidine, 1-[(2E,4E)-5-(1,3-benzodioxol-5-yl)
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Vitiligo [ICD-11: ED63.0; ICD-10: L80-L99, L80; ICD-9: 709.01] | Phase 1/2 | [1], [2] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C17H19NO3
|
|||
| Canonical SMILES |
C1CCN(CC1)C(=O)C=CC=CC2=CC3=C(C=C2)OCO3
|
|||
| InChI |
1S/C17H19NO3/c19-17(18-10-4-1-5-11-18)7-3-2-6-14-8-9-15-16(12-14)21-13-20-15/h2-3,6-9,12H,1,4-5,10-11,13H2/b6-2+,7-3+
|
|||
| InChIKey |
MXXWOMGUGJBKIW-YPCIICBESA-N
|
|||
| CAS Number |
CAS 94-62-2
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
6615, 84021, 589162, 1916561, 3134289, 8138057, 8144276, 8149678, 8704601, 10321424, 10538527, 10584664, 11537714, 14775491, 24898568, 24901388, 26531569, 26612115, 26680012, 26748436, 26748437, 26753730, 29204493, 43760287, 47365277, 47440351, 47662373, 47885490, 47959849, 48110525, 48259326, 48414997, 48423957, 49698510, 49748464, 49856282, 50107401, 50107402, 53789346, 53801087, 56463241, 57394548, 57407729, 78531100, 81065204, 81092942, 85272433, 87574654, 88802195, 92124496
|
|||
| ChEBI ID |
CHEBI:28821
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2489). | |||
| REF 2 | ClinicalTrials.gov (NCT01383694) Effect Of Piperine In Patients With Oropharyngeal Dysphagia. U.S. National Institutes of Health. | |||
| REF 3 | Proposed structural basis of interaction of piperine and related compounds with monoamine oxidases. Bioorg Med Chem Lett. 2010 Jan 15;20(2):537-40. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.